Heart Rhythm O2最新文献

{"title":"A negative relationship between first-pass pulmonary vein isolation and body mass index in ablation index–guided pulmonary vein isolation","authors":"Hideharu Okamatsu MD ,&nbsp;Ken Okumura MD, PhD ,&nbsp;Fumitaka Onishi MD ,&nbsp;Akino Yoshimura MD, PhD ,&nbsp;Kodai Negishi MD ,&nbsp;Takuo Tsurugi MD, PhD ,&nbsp;Yasuaki Tanaka MD, PhD ,&nbsp;Miki Fujita MD, PhD ,&nbsp;Koichi Nakao MD, PhD ,&nbsp;Tomohiro Sakamoto MD, PhD ,&nbsp;Junjiro Koyama MD, PhD ,&nbsp;Hirofumi Tomita MD, PhD","doi":"10.1016/j.hroo.2024.09.020","DOIUrl":"10.1016/j.hroo.2024.09.020","url":null,"abstract":"<div><h3>Background</h3><div>We previously reported the relationship between first-pass pulmonary vein isolation (FPI) and pulmonary vein isolation (PVI) durability in ablation index–guided atrial fibrillation ablation. Obesity is a worsening factor for atrial tachyarrhythmia (AT) recurrence. However, the impact of obesity on FPI has been scarcely reported. General anesthesia (GA) facilitates completing PVI by preventing airway obstruction caused by sedative drug use. However, the impact of GA on the relationship also has not been elucidated.</div></div><div><h3>Objective</h3><div>The study sought to evaluate the impact of obesity and its relationship with GA on FPI.</div></div><div><h3>Methods</h3><div>We retrospectively studied 2187 consecutive patients undergoing ablation index–guided first atrial fibrillation ablation (conscious sedation in 1969 and GA in 218). We divided them into 4 groups according to body mass index (BMI): underweight (BMI &lt; 18.5 kg/m2) (n = 80), normal (18.5 kg/m2 ≤ BMI &lt; 25 kg/m2) (n = 1,160), overweight (25 kg/m2 ≤ BMI &lt; 30 kg/m2) (n = 763), and obesity (BMI ≥30 kg/m2) (n = 184).</div></div><div><h3>Results</h3><div>FPI rate decreased as BMI increased in both conscious sedation (68.1% in underweight, 61.5% in normal, 48.7% in overweight, and 39.0% in obesity; <em>P &lt;</em> .001) and GA (87.5%, 67.1%, 61.3%, and 44.7%, respectively; <em>P =</em> .01). Multivariate analysis revealed overweight (odds ratio 0.65, 95% confidence interval [CI] 0.53–0.79, <em>P &lt;</em> .001, vs normal) and obesity (OR 0.44, 95% CI 0.31–0.62 <em>P &lt;</em> .001, vs normal) as independent predictors for FPI and obesity as an AT recurrence predictor (hazard ratio 1.35, 95% CI 1.01–1.81, <em>P =</em> .04).</div></div><div><h3>Conclusion</h3><div>BMI increase was negatively related to the FPI rate. Notably, the FPI rate in obese patients, even under GA, was low, which might be related to their high AT recurrence.</div></div>","PeriodicalId":29772,"journal":{"name":"Heart Rhythm O2","volume":"5 12","pages":"Pages 890-899"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11721731/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142972286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Providing medical care in health resource–constrained global areas: Syria","authors":"Uma N. Srivatsa MBBS, MAS","doi":"10.1016/j.hroo.2024.10.009","DOIUrl":"10.1016/j.hroo.2024.10.009","url":null,"abstract":"","PeriodicalId":29772,"journal":{"name":"Heart Rhythm O2","volume":"5 12","pages":"Pages 860-861"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11721719/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142972323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Analysis of junctional beats during slow pathway ablation: Illuminating the mechanism of typical and atypical AV nodal re-entrant tachycardia","authors":"Phuong Ngo Thanh Nguyen MD ,&nbsp;Yumi Katsume MD ,&nbsp;Akiko Ueda MD ,&nbsp;Seiichiro Matsuo MD ,&nbsp;Noriko Nonoguchi MD ,&nbsp;Hirotsugu Ikewaki MD ,&nbsp;Takato Mohri MD ,&nbsp;Kyoko Hoshida MD ,&nbsp;Mika Tashiro MD ,&nbsp;Toshiaki Sato MD ,&nbsp;Ikuko Togashi MD ,&nbsp;Kyoko Soejima MD","doi":"10.1016/j.hroo.2024.09.021","DOIUrl":"10.1016/j.hroo.2024.09.021","url":null,"abstract":"<div><h3>Background</h3><div>Junctional rhythm (JR) frequently occurs during radiofrequency (RF) ablation procedures targeting the slow pathway (SP) for atrioventricular nodal re-entrant tachycardia (AVNRT), signaling successful ablation. Two types of JR have been noticed: typical JR as His activation preceding atrial activation, and atypical JR as atrial activation preceding the His activation. Nevertheless, the origin and characteristics of JR remain incompletely defined.</div></div><div><h3>Objective</h3><div>This study aimed to investigate whether JR induced by RF ablation at the anatomical SP position could reveal preferential conduction in the antegrade vs the retrograde direction.</div></div><div><h3>Methods</h3><div>Consecutive RF ablation procedures targeting the SP for AVNRT were performed in 40 patients. Using electroanatomic mapping, the coronary sinus ostium, His bundle, RF sites, and the distances between these sites and the RF sites (n = 216) were analyzed. We compared the H-A and A-H intervals during AVNRT and JR.</div></div><div><h3>Results</h3><div>In typical AVNRT, the H-A_JR resembled the H-A_AVNRT with an identical atrial activation sequence, supporting JR conduction to the atrium via a fast pathway. The atypical AVNRT group displayed a significantly shorter A-H_JR than the A-H_AVNRT (<em>P &lt;</em> .0001) with identical atrial activation. The JR incidence in patients with both typical and atypical AVNRT showed no correlation with the RF site location.</div></div><div><h3>Conclusion</h3><div>For patients with typical AVNRT, JR induced by SP ablation preferentially followed the fast pathway. In patients with atypical AVNRT and with retrograde SP conduction, a shorter A-H interval during JR, with the same atrial sequence as that observed during atypical AVNRT, implies retrograde conduction from the SP to the atrium.</div></div>","PeriodicalId":29772,"journal":{"name":"Heart Rhythm O2","volume":"5 12","pages":"Pages 910-916"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11721727/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142972290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"High-power short-duration setting prevents changes of periprocedural thrombotic markers and the onset of silent stroke in patients with atrial fibrillation","authors":"Masashi Kamioka MD,&nbsp;Tomonori Watanabe MD,&nbsp;Hiroaki Watanabe MD,&nbsp;Takafumi Okuyama MD,&nbsp;Ayako Yokota MD,&nbsp;Takahiro Komori MD,&nbsp;Tomoyuki Kabutoya MD,&nbsp;Yasushi Imai MD,&nbsp;Kazuomi Kario MD, PhD","doi":"10.1016/j.hroo.2024.09.019","DOIUrl":"10.1016/j.hroo.2024.09.019","url":null,"abstract":"<div><h3>Background</h3><div>It remains unclear whether the newly adopted high-power, short-duration (HP-SD) setting in ablation for atrial fibrillation (AF) impacts periprocedural thrombotic markers or silent stroke (SS) onset.</div></div><div><h3>Objective</h3><div>The aim of the present study was to investigate the clinical impact of HP-SD setting ablation on changes in periprocedural thrombotic markers and the onset of SS.</div></div><div><h3>Methods</h3><div>We enrolled 101 AF patients: the HP-SD group (n = 67) using 50 W and the conventional ablation group (n = 34) using 30 to 40 W. D-dimer, thrombin-antithrombin complex (TAT), and total plasminogen activator inhibitor-1 (tPAI-1) were analyzed the day before, immediately after, and 1 day after the procedure. Magnetic resonance imaging was performed within 48 hours after the procedure.</div></div><div><h3>Results</h3><div>Left atrial dwelling time was significantly shorter in the HP-SD group (<em>P &lt;</em> .05). In the conventional ablation group, the D-dimer and tPAI-1 levels continued to increase until 1 day postprocedure, while the TAT peaked immediately after the ablation. On the other hand, the range of the variation of these thrombotic markers in the HP-SD group was smaller. SS occurred more frequently in the conventional ablation group than in the HP-SD group (26% vs 5%, <em>P &lt;</em> .05). In the logistic regression analysis, the HP-SD setting and TAT difference (postprocedure – preprocedure) were independent predictors for SS (odds ratios 0.141 and 5.838, respectively; <em>P &lt;</em> .05).</div></div><div><h3>Conclusions</h3><div>The HP-SD setting led to a shorter left atrial dwelling time and reduced change in thrombotic markers, resulting in lower prevalence of SS.</div></div>","PeriodicalId":29772,"journal":{"name":"Heart Rhythm O2","volume":"5 12","pages":"Pages 917-924"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11721730/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142972294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of body mass index on in-hospital outcomes in patients receiving leadless pacemakers: A five-category analysis","authors":"Rajveer Sagoo BS ,&nbsp;Navraj S. Sagoo MD ,&nbsp;Ali S. Haider BS ,&nbsp;Mohanakrishnan Sathyamoorthy MD","doi":"10.1016/j.hroo.2024.09.017","DOIUrl":"10.1016/j.hroo.2024.09.017","url":null,"abstract":"<div><h3>Background</h3><div>The adoption of leadless pacemakers (LPMs) is increasing, yet the impact of body mass index (BMI) on procedural outcomes remains underexplored.</div></div><div><h3>Objective</h3><div>The purpose of this study was to explore the impact of BMI on in-hospital outcomes for patients receiving LPM implantation.</div></div><div><h3>Methods</h3><div>Data from the National Inpatient Sample from 2018–2021 were analyzed for patients older than 18 years who underwent LPM implantation, with specific inclusion and exclusion criteria applied. Patients were identified using <em>International Classification of Diseases 10th Revision</em> codes and categorized into BMI groups: underweight, normal, overweight, obese, and morbidly obese. The primary outcome assessed was in-hospital mortality. Secondary outcomes included blood transfusion, pericardial complications, infection/inflammation, removal/revision, and other complications.</div></div><div><h3>Results</h3><div>The study included 3832 patients who underwent LPM implantation between 2018 and 2021, weighted to represent 19,610 patients, with 3540 having an appropriate BMI designation. Mortality was lower in the obese group (2.3%) compared to the nonobese group (2.7%) (adjusted odds ratio [aOR] 0.462, 95% confidence interval [CI] 0.259–0.623, <em>P</em> = .009). Compared to the normal weight group, those categorized as overweight, obese, and morbidly obese demonstrated a lower risk of in-hospital mortality (aOR 0.432, 95% CI 0.299–0.734, <em>P</em> = .009; aOR 0.465, 95% CI 0.238–0.721, <em>P</em> &lt;.001; aOR 0.299, 95% CI 0.153–0.586, <em>P</em> &lt;.001, respectively).</div></div><div><h3>Conclusion</h3><div>These findings support the existence of the obesity paradox in patients with LPM implantation, where higher BMI categories are associated with improved mortality outcomes, meeting our prespecified primary endpoint. Further studies are needed to clarify the mechanisms behind these observations.</div></div>","PeriodicalId":29772,"journal":{"name":"Heart Rhythm O2","volume":"5 12","pages":"Pages 883-889"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11721722/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142972295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"VO-03 EFFICACY OF CATHETER ABLATION OF FREQUENT ASYMPTOMATIC IDIOPATHIC PREMATURE VENTRICULAR COMPLEXES IN TREATING LATENT LEFT VENTRICULAR SYSTOLIC DYSFUNCTION AS ASSESSED BY SPECKLE TRACKING OF LEFT VENTRICULAR GLOBAL LONGITUDINAL STRAIN","authors":"Hesham Tarek,&nbsp;Hayam El Damanhoury,&nbsp;Mohammed Moussa,&nbsp;Ahmed Gamal El Din,&nbsp;Haitham Badran,&nbsp;John Kamel Zarif","doi":"10.1016/j.hroo.2024.10.014","DOIUrl":"10.1016/j.hroo.2024.10.014","url":null,"abstract":"","PeriodicalId":29772,"journal":{"name":"Heart Rhythm O2","volume":"5 12","pages":"Pages S3-S4"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143180954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Validation, bias assessment, and optimization of the UNAFIED 2-year risk prediction model for undiagnosed atrial fibrillation using national electronic health data","authors":"Mohammad Ateya PharmD, MS ,&nbsp;Danai Aristeridou MSc ,&nbsp;George H. Sands MD ,&nbsp;Jessica Zielinski BS ,&nbsp;Randall W. Grout MD, MS ,&nbsp;A. Carmine Colavecchia PharmD, PhD ,&nbsp;Oussama Wazni MD, FHRS ,&nbsp;Saira N. Haque PhD, MHSA","doi":"10.1016/j.hroo.2024.09.010","DOIUrl":"10.1016/j.hroo.2024.09.010","url":null,"abstract":"<div><h3>Background</h3><div>Prediction models for atrial fibrillation (AF) may enable earlier detection and guideline-directed treatment decisions. However, model bias may lead to inaccurate predictions and unintended consequences.</div></div><div><h3>Objective</h3><div>The purpose of this study was to validate, assess bias, and improve generalizability of “UNAFIED-10,” a 2-year, 10-variable predictive model of undiagnosed AF in a national data set (originally developed using the Indiana Network for Patient Care regional data).</div></div><div><h3>Methods</h3><div>UNAFIED-10 was validated and optimized using Optum de-identified electronic health record data set. AF diagnoses were recorded in the January 2018–December 2019 period (outcome period), with January 2016–December 2017 as the baseline period. Validation cohorts (patients with AF and non-AF controls, aged ≥40 years) comprised the full imbalanced and randomly sampled balanced data sets. Model performance and bias in patient subpopulations based on sex, insurance, race, and region were evaluated.</div></div><div><h3>Results</h3><div>Of the 6,058,657 eligible patients (mean age 60 ± 12 years), 4.1% (n = 246,975) had their first AF diagnosis within the outcome period. The validated UNAFIED-10 model achieved a higher C-statistic (0.85 [95% confidence interval 0.85–0.86] vs 0.81 [0.80–0.81]) and sensitivity (86% vs 74%) but lower specificity (66% vs 74%) than the original UNAFIED-10 model. During retraining and optimization, the variables insurance, shock, and albumin were excluded to address bias and improve generalizability. This generated an 8-variable model (UNAFIED-8) with consistent performance.</div></div><div><h3>Conclusion</h3><div>UNAFIED-10, developed using regional patient data, displayed consistent performance in a large national data set. UNAFIED-8 is more parsimonious and generalizable for using advanced analytics for AF detection. Future directions include validation on additional data sets.</div></div>","PeriodicalId":29772,"journal":{"name":"Heart Rhythm O2","volume":"5 12","pages":"Pages 925-935"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11721729/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142972328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"VO-05 FACTORS ASSOCIATED WITH NONUPTAKE OF IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (ICD) AMONG ELIGIBLE PATIENTS AT A TERTIARY HOSPITAL IN KENYA","authors":"Emmanuel Oluoch,&nbsp;Jasmit Shah,&nbsp;Mohamed Varwani,&nbsp;Mohamed Jeilan,&nbsp;Mzee Ngunga","doi":"10.1016/j.hroo.2024.10.016","DOIUrl":"10.1016/j.hroo.2024.10.016","url":null,"abstract":"","PeriodicalId":29772,"journal":{"name":"Heart Rhythm O2","volume":"5 12","pages":"Pages S4-S5"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143179714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"VO-06 SUCCESS AND COMPLICATION RATES OF LEAD EXTRACTION AT THE NATIONAL HEART INSTITUTE","authors":"Samhaa Alsayed Hamed,&nbsp;Azza Katta,&nbsp;Mostafa Mansy,&nbsp;Mahmoud Elsherif,&nbsp;Mohamed Abou Alhassan,&nbsp;Haitham Badran,&nbsp;Ahmed Eldamaty,&nbsp;Mohamed Ossama","doi":"10.1016/j.hroo.2024.10.017","DOIUrl":"10.1016/j.hroo.2024.10.017","url":null,"abstract":"","PeriodicalId":29772,"journal":{"name":"Heart Rhythm O2","volume":"5 12","pages":"Pages S5-S6"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143180160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Risk of stroke with reduced dose direct oral anticoagulants vs standard dose anticoagulation after cardioversion of atrial fibrillation: A systematic review and meta-analysis","authors":"Travis Quevillon MD ,&nbsp;Erik Slade MD ,&nbsp;Faith Michael MD ,&nbsp;Alexander P. Benz MD, MSc ,&nbsp;William F. McIntyre MD, PhD ,&nbsp;Ratika Parkash MD, MSc ,&nbsp;Jeff S. Healey MD, MSc ,&nbsp;Dennis T. Ko MD, MSc ,&nbsp;Mohammed Shurrab MD, MSc, PhD","doi":"10.1016/j.hroo.2024.09.011","DOIUrl":"10.1016/j.hroo.2024.09.011","url":null,"abstract":"<div><h3>Background</h3><div>There is consensus on the safety of standard dose direct oral anticoagulants (DOACs) for stroke prevention in patients undergoing cardioversion of atrial fibrillation (AF), but outcomes of reduced dose DOACs in this setting remain unclear.</div></div><div><h3>Objective</h3><div>This systematic review and meta-analysis aimed to compare the rate of cardioversion-associated thromboembolic events between patients taking reduced dose DOACs and those receiving standard dose anticoagulation.</div></div><div><h3>Methods</h3><div>A systematic search was conducted for studies published between January 1, 2009, and February 16, 2024 in PubMed, Embase, and Cochrane Central Register of Controlled Trials. The included studies compared the rate of thromboembolic events in patients with AF undergoing cardioversion on reduced dose DOACs with the rate in those on standard dose anticoagulation. Odds ratios were pooled with a random effects model.</div></div><div><h3>Results</h3><div>We identified 2 randomized controlled trials and 8 cohort studies, which included 5212 patients with AF who underwent cardioversion on anticoagulation (1010 patients on reduced dose DOACs and 4202 patients on standard dose anticoagulation). Follow-up ranged from 3 hours to 90 days after cardioversion. There was a numerically higher rate of thromboembolic events in patients undergoing cardioversion on reduced dose DOACs than in those on standard dose anticoagulation (0.69% vs 0.29%; odds ratio 1.98; 95% confidence interval 0.72–5.45; <em>P</em> = .19; I² = 0%); however, the difference was not statistically significant.</div></div><div><h3>Conclusion</h3><div>Our systematic review and meta-analysis suggests that there is a numerically higher risk of thromboembolic events in patients with AF undergoing cardioversion on reduced dose DOACs than in those on standard dose anticoagulation. However, the difference was not statistically significant. These findings raise concern about the safety of reduced dose DOACs in patients undergoing cardioversion.</div></div>","PeriodicalId":29772,"journal":{"name":"Heart Rhythm O2","volume":"5 12","pages":"Pages 942-950"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11721732/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142972325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}